Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study

Rahbar, Kambiz; Essler, Markus; Pabst, Kim M.; Eiber, Matthias; la Fouge, Christian; Prasad, Vikas; Rassek, Philipp; Hasa, Ergela; Dittmann, Helmut; Bundschuh, Ralph A.; Fendler, Wolfgang P.; Kurtinecz, Milena; Schmall, Anja; Verholen, Frank; Sartor, Oliver

Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study

Autor(en):

Rahbar, Kambiz; Essler, Markus; Pabst, Kim M.; Eiber, Matthias; la Fouge, Christian; Prasad, Vikas; Rassek, Philipp; Hasa, Ergela; Dittmann, Helmut; Bundschuh, Ralph A.; Fendler, Wolfgang P.; Kurtinecz, Milena; Schmall, Anja; Verholen, Frank; Sartor, Oliver

Tübinger Autor(en):

Dittmann, Helmut
La Fougère, Christian Jean

Erschienen in:

Journal of Nuclear Medicine (2023), Bd. 64, H. 4, S. 574-578

Verlagsangabe:

Reston : Soc Nuclear Medicine Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.2967/jnumed.122.264456

ISSN:

0161-5505